Molecular Lymph Node Staging in Bladder Urothelial Carcinoma: Impact on Survival

European Urology

Volumn 54, Issue 6, 2008, Pages 1363-1372

  Marín Aguilera, Mercedes ^a,b   Mengual, Lourdes ^a,b   Burset, Moisès ^a,b   Oliver, Artur ^b   Ars, Elisabet ^b   Ribal, María José ^a   Colomer, Dolors ^a   Mellado, Begoña ^a   Villavicencio, Humberto ^b   Algaba, Ferran ^b   Alcaraz, Antonio ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b FUNDACIÓ PUIGVERT   (Spain)

Author keywords

Carcinoma; Lymphatic metastasis; Molecular diagnostic techniques; Real time RT PCR; Transitional cell; Tumour markers

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER UROTHELIUM CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DNA MICROARRAY; FEMALE; FOLLOW UP; FXYD3 GENE; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE ISOLATION; HISTOPATHOLOGY; HUMAN; KRT20 GENE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UNINDEXED SEQUENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 55649123475     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.04.059     Document Type: Article

References (30)

1. Stein J.P., Quek M.L., and Skinner D.G. Lymphadenectomy for invasive bladder cancer. II. Technical aspects and prognostic factors. BJU Int 97 (2006) 232-237
2. Madersbacher S., Hochreiter W., Burkhard F., et al. Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 21 (2003) 690-696
3. Nissan A., Jager D., Roystacher M., et al. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients. Br J Cancer 94 (2006) 681-685
4. Weitz J., Kienle P., Magener A., et al. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res 5 (1999) 1830-1836
5. Sonoda H., Yamamoto K., Kushima R., et al. Detection of lymph node micrometastasis in pN0 early gastric cancer: efficacy of duplex RT-PCR with MUC2 and TFF1 in mucosal cancer. Oncol Rep 16 (2006) 411-416
6. Ahn J.M., Rayamajhi N., Gyun K.S., and Sang Y.H. Comparison of real-time reverse transcriptase-polymerase chain reaction and nested or commercial reverse transcriptase-polymerase chain reaction for the detection of hepatitis E virus particle in human serum. Diagn Microbiol Infect Dis 56 (2006) 269-274
7. Wu X., Kakehi Y., Zeng Y., Taoka R., Tsunemori H., and Inui M. Uroplakin II as a promising marker for molecular diagnosis of nodal metastases from bladder cancer: comparison with cytokeratin 20. J Urol 174 (2005) 2138-2142
8. Seraj M.J., Thomas A.R., Chin J.L., and Theodorescu D. Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder. Clin Cancer Res 7 (2001) 1516-1522
9. Kurahashi T., Hara I., Oka N., Kamidono S., Eto H., and Miyake H. Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for focally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II. Clin Cancer Res 11 (2005) 3773-3777
10. Gudemann C.J., Weitz J., Kienle P., et al. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma. J Urol 164 (2000) 532-536
11. Lopez-Beltran A., Sauter G., Gasser T., et al. World Health Organization. Classification of Tumours. Pathology and Genetics. Tumours of the Urinary System and Male Genital Organs (2004), IARC Press, Lyon
12. Ribal M.J., Mengual L., Marin M., Algaba F., et al. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging. Anticancer Res 26 (2006) 411-419
13. Pantel K., Cote R.J., and Fodstad O. Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 91 (1999) 1113-1124
14. Zhang J.S., Gong A., Cheville J.C., Smith D.I., and Young C.Y. AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer. Genes Chromosomes Cancer 43 (2005) 249-259
15. Kayed H., Kleeff J., Kolb A., et al. FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth. Int J Cancer 118 (2006) 43-54
16. Morrison B.W., Moorman J.R., Kowdley G.C., Kobayashi Y.M., Jones L.R., and Leder P. Mat-8, a novel phospholemman-like protein expressed in human breast tumors, induces a chloride conductance in Xenopus oocytes. J Biol Chem 270 (1995) 2176-2182
17. Vaarala M.H., Porvari K., Kyllonen A., and Vihko P. Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression. Lab Invest 80 (2000) 1259-1268
18. Tao L., Lefevre M., Ricci S., et al. Detection of occult carcinomatous diffusion in lymph nodes from head and neck squamous cell carcinoma using real-time RT-PCR detection of cytokeratin 19 mRNA. Br J Cancer 94 (2006) 1164-1169
19. Ismail M.S., Wynendaele W., Aerts J.L., et al. Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCR. Clin Cancer Res 10 (2004) 196-201
20. Bosma A.J., Weigelt B., Lambrechts A.C., et al. Detection of circulating breast tumor cells by differential expression of marker genes. Clin Cancer Res 8 (2002) 1871-1877
21. Gazzaniga P., Gandini O., Giuliani L., et al. Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients. Clin Cancer Res 7 (2001) 577-583
22. Vlems F.A., Ladanyi A., Gertler R., et al. Reliability of quantitative reverse-transcriptase-PCR-based detection of tumour cells in the blood between different laboratories using a standardised protocol. Eur J Cancer 39 (2003) 388-396
23. Weigelt B., Verduijn P., Bosma A.J., Rutgers E.J., Peterse H.L., and van't Veer L.J. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers. Br J Cancer 90 (2004) 1531-1537
24. Liedberg F., and Månsson W. Lymph node metastasis in bladder cancer. Eur Urol 49 (2006) 13-21
25. Vieweg J., Whitmore Jr. W.F., Herr H.W., et al. The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experience. Cancer 73 (1994) 3020-3028
26. Lerner S.P., Skinner D.G., Lieskovsky G., et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol 149 (1993) 758-764
27. Ghoneim M.A., el-Mekresh M.M., el-Baz M.A., el-Attar I.A., and Ashamallah A. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1026 cases. J Urol 158 (1997) 393-399
28. Poulsen A.L., Horn T., and Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 160 (1998) 2015-2019
29. Vieweg J., Gschwend J.E., Herr H.W., and Fair W.R. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 161 (1999) 449-454
30. TNM Classification of Malignant Tumours, 6th ed. New York: Wiley; 2002.